Skip to main content
Show full summary

The Lord Bishop of Exeter to ask His Majesty's Government what assessment they have made of the cost effectiveness of Evusheld in the treatment of immuno-compromised persons with complex health needs against the cost of an admission to hospital, given the increase in COVID-19 hospital admissions and the pressure on the NHS. 	HL4549

Question HL4549: tabled on 9 January 2023 and due for answer by 23 January 2023

This type of business sits within the Questions & Statements category.

This question has been answered by the relevant Government Department.

Question text

The Lord Bishop of Exeter to ask His Majesty's Government what assessment they have made of the cost effectiveness of Evusheld in the treatment of immuno-compromised persons with complex health needs against the cost of an admission to hospital, given the increase in COVID-19 hospital admissions and the pressure on the NHS. 	HL4549
Legend for business item text
Item that is new or altered.
* Item is an oral question.
Numbers starting HL are unique identifiers for written questions, Bills or papers.

Member's Registered Interests

There are no interests to show.